Intramuscular ziprasidone: An effective agent for sedation of the agitated ED patient [4]

American Journal of Emergency Medicine

Volumn 24, Issue 2, 2006, Pages 254-255

  Fulton, Jessica A ^a   Axelband, Jennifer ^a   Jacoby, Jeanne L ^a   Heller, Michael B ^b  

^a NEW YORK UNIVERSITY   (United States)

^b ST LUKE S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGITATION; BRIEF PSYCHIATRIC RATING SCALE; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; LETTER; MOTOR ACTIVITY; PRIORITY JOURNAL; QT PROLONGATION; SEDATION; VERBAL BEHAVIOR;

ADULT; ANTIPSYCHOTIC AGENTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAMUSCULAR; MALE; PAIN MEASUREMENT; PIPERAZINES; PROSPECTIVE STUDIES; PSYCHOMOTOR AGITATION; THIAZOLES;

EID: 33144457591     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2005.09.007     Document Type: Letter

References (7)

1. C.G. McCormick FDA Alert: current FDA Report on Droperidol Status and Basis for 'Black Box' Warning ASA Newsl 66 2002
2. D.G. Daniel, and L.F. Copeland Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic Expert Opin Investig Drugs 9 4 2000 819 828
3. M.L. Martel Ziprasidone for sedation of the agitated ED patient Am J Emerg Med 22 3 2004 238
4. T. Baptista, J. Zarate, and R. Joober Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics Curr Drug Targets 5 3 2004 279 299
5. D.G. Daniel Tolerability of ziprasidone: an expanding perspective J Clin Psychiatry 64 Suppl 19 2003 40 49
6. D.G. Daniel, S.G. Potkin, and K.R. Reeves Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial Psychopharmacology 155 2001 128 134
7. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812,11:1774-82.